Hematologic Malignancies at the Cutting Edge of Immunotherapy, Expert Says – Targeted Oncology
|
Hematologic Malignancies at the Cutting Edge of Immunotherapy, Expert Says
Targeted Oncology “I think that we have always been ahead of the curve—as far as moving new treatments forward—and with respect to immunotherapy, we are also at the cutting edge,” said Leonard, a professor of medicine at Weill Cornell Medicine/NewYork-Presbyterian … |
